Biotech company Horizon Therapeutics’ are set to hire 100 new staff in Dublin and Waterford over the next 18 months.
Half of the jobs will be located in Horizon Therapeutics’ Waterford manufacturing facility, while the rest will be at the company’s new global HQ in Dublin. The company purchased the facility in 2021 from EirGen Pharma to support the growth of its on-market rare disease medicines and pipeline biologics.
The roles in Waterford will be high-end science and engineering specialist roles, which the company hopes to have filled by the end of this year.
Horizon Therapeutics employs around 200 people in Ireland across a variety of key functions including finance, legal, technical operations and research and development.
Its operation is focused on the discovery, development and commercialisation of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Globally, it has around 2,000 employees.
Timothy P Walbert, CEO of Horizon Therapeutics, said:
“Ireland has been a wonderful location for Horizon for nearly 10 years and we as a company benefit enormously from the rich pool of talented and enthusiastic employees here. Ireland is a key part of our global strategy and we will continue to invest significantly here to enhance our business and to demonstrate our support for the wider community.”